成人伊人青草久久综合网,日韩电影一二三区,中文字幕一区二区在线播放,久久一区视频,a级片中文字幕,销魂美女杨依大尺度啪啪,亚洲国产系列久久精品99人人

首頁(yè) /科研細(xì)胞 /人源細(xì)胞系 /血液 /MEC-1(人白血病細(xì)胞)

MEC-1(人白血病細(xì)胞)

CBP60514

詢 價(jià)
索取STR
產(chǎn)品描述
產(chǎn)品數(shù)據(jù)庫(kù)
I. General information 
Synonyms: MEC-1
Background: established in 1993 from the peripheral blood of a 61-year-old Caucasian man with chronic B cell leukemia (B-CLL in prolymphocytoid transformation to B-PLL); serial sister cell line of MEC-2 (DSMZ ACC 500)
Species: human (Homo sapiens)
Tissue: N/A 
Disease: chronic B cell leukemia
Gender: N/A 
Morphology: round to polymorphic cells growing in suspension, singly or partly in small aggregates, a few cells are slightly adherent;
Growth Mode: N/A 
Doubling Time: ca. 40 hours
DNA Profile: N/A
Cobioer’s Cell Line Authentication Service
Culture Medium:

IMDM+20%FBS

MEC-1完全培養(yǎng)基,# CBP60514M
We strongly suggest to purchase the complete medium from Cobioer.

Cryopreservation medium: 90%FBS+10%DMSO
Mycoplasma: contamination was eliminated with BM-Cyclin (tiamulin & minocycline), then negative in microbiological culture, RNA hybridization, PCR assays
Immunology: CD3 -, CD10 -, CD13 -, CD19 +, CD20 +, CD34 -, CD37 +, CD38 +, cyCD79a +, CD80 +, CD138 +, HLA-DR +; image
Fingerprint: same DNA profile as MEC-2 using multiplex PCR of minisatellite markers
Species: confirmed originally as human by cytogenetics
Cytogenetics: human near-diploid karyotype with 10% polyploidy - 46(44-47)<2n>XY, -2, +7, -12, +1-2mar, t(1;6)(q22-23;p21), add(7)(q11), der(10)(10pter->q22::?::2q11->qter), del(17)(p11) - small acf/mar present in most cells - resembles published karyotype
Virus   PCR: EBV +, HBV -, HCV -, HIV-1 -, HIV-2 -, HTLV-I/II -, MLV -, SMRV -
Comments: For more information, please contact Cobioer (4008-750-250).

客服

微信

掃一掃,添加二維碼

電話

留言

藥靶模型聯(lián)系方式: 華東銷售經(jīng)理:18240630236 全國(guó)銷售經(jīng)理:18066071954
診斷標(biāo)準(zhǔn)品聯(lián)系方式: 華東銷售經(jīng)理:15000320447 華北銷售經(jīng)理:18131625521 華南銷售經(jīng)理:13484295986 華中&西南銷售經(jīng)理:13871580511 全國(guó)銷售經(jīng)理:13484295986

掃二維碼

立即提交